Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFirst-Line Combination Immunotherapy Prolongs Survival in BRAF Advanced Melanoma.AuthorsBecze, ElisaAbstractThe article focuses on First-Line Combination Immunotherapy Prolongs Survival in BRAF Advanced Melanoma.SubjectsTHERAPEUTIC use of monoclonal antibodies; MELANOMA; COMBINED modality therapy; IMMUNOTHERAPYPublicationONS Voice, 2022, Vol 37, Issue 4, p7ISSN2475-6938Publication typeArticle